Sleep medicine in pneumology

Diagnosis and treatment of sleep related breathing disorders have become an essential challenge of internal medicine. They are highly important clinically because of the impairment of daytime performance, attention and concentration with elevated risk of accidents in workplace and traffic and becaus...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Deutsche medizinische Wochenschrift (1946) Ročník 136; číslo 14; s. 706
Hlavní autor: Randerath, W J
Médium: Journal Article
Jazyk:němčina
Vydáno: Germany 01.04.2011
Témata:
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Comorbidity
Diagnosis, Differential
Disorders of Excessive Somnolence - diagnosis
Disorders of Excessive Somnolence - etiology
Disorders of Excessive Somnolence - therapy
Humans
Polysomnography
Pulmonary Embolism - diagnosis
Pulmonary Embolism - etiology
Pulmonary Embolism - therapy
Risk Factors
Sleep Apnea, Obstructive - complications
Sleep Apnea, Obstructive - diagnosis
Sleep Apnea, Obstructive - etiology
Sleep Apnea, Obstructive - therapy
ISSN:1439-4413, 1439-4413
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Diagnosis and treatment of sleep related breathing disorders have become an essential challenge of internal medicine. They are highly important clinically because of the impairment of daytime performance, attention and concentration with elevated risk of accidents in workplace and traffic and because of their consequences on cardiovascular and metabolic disorders. The obstructive sleep apnoea syndrome (OSAS) has proven to be one of the most important risk factors for arteriosclerosis, especially in the cerebral vessels. OSAS induces arterial hypertention and increases mortality due to cardiovascular diseases. Sleep related breathing disorders induce hyperglycemia and dyslipidemia. OSAS and the metabolic syndrome increase the cardiovascular risk additively. Moreover, cardiac disorders, such as arterial hypertention, heart failure and arterial fibrillation, can induce central breathing disturbances. This impairs the prognosis of affected patients substantially. Atypical symptoms of obstructive sleep apnoea (daytime sleepiness, snoring, witnessed apnoea) are often absent in these patients. In contrast patients often suffer from fatigue, reduced daytime performance, and depression which is a major challenge to diagnosis. This review presents new data on these aspects. Moreover, the association of sleep apnoea and pulmonary embolism and the question of optimal sleep duration are addressed.
Bibliografie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:1439-4413
1439-4413
DOI:10.1055/s-0031-1274569